logo

Research

Help: To find Illnesses or Conditions associated with a Herbal Remedy. Select a letter from A - Z of Herbal Remedies. Or Scroll lists. Or Use Search.

Stinging Nettle Remedies


Stinging Nettle - Herbal Research
A WHO Organizational resource: Stinging Nettle - FULL REPORT


Medicinal uses supported by clinical data
Symptomatic treatment of lower urinary tract disorders (nocturia, polyuria, urinary retention) resulting from BPH stages I and II, as
defined by Alken, in cases where diagnosis of prostate cancer is negative (22–35).

 
Uses described in pharmacopoeias and traditional systems of medicine
As a diuretic and for the treatment of rheumatism and sciatica (6).
 
Uses described in folk medicine, not supported by experimental or clinical data
Treatment of asthma, coughs, dandruff, diabetes, diarrhoea, eczema, fever, gout,  haemorrhoids,  nose  bleeds,  scurvy,  snakebites  and  tuberculosis  (5,6). The plant has also been used to stop uterine bleeding after childbirth, increase lactation and promote hair growth, and as a vermifuge (5,6)

References:

5.     Farnsworth  NR,  ed. NAPRALERT  database Chicago,  University  of  Illinois at Chicago, IL, February 9, 1998 production (an online database available  directly  through  the  University  of  Illinois  at  Chicago  or  through the 
Scientific and Technical Network [STN] of Chemical Abstracts Services).
 
 6.    Patten G. Urtica. Australian Journal of Medical Herbalism, 1993, 5:5–13.
 
22.   Bauer  HW  et  al.  Endokrine  Parameter  während  der  Behandlung  der  benignen Prostatahyperplasie mit ERU. In: Bauer HW, ed. Benigne Prostatahyperplasie  II,  klinische  und  experimentelle  Urologie  19 Munich,  Zuckschwerdt, 1988.
 
23.  Belaiche P, Lievoux O. Clinical studies on the palliative treatment of prostatic  adenoma  with  extract  of  
Urtica root. Phytotherapy  Research,  1991, 5:267–269.
 
24.  Dathe  G,  Schmid  H.  Phytotherapie  der  benignen  Prostatahyperplasie  (BPH). Doppelblindstudie mit Extraktum Radicis Urticae (ERU). Urologie [B], 1987, 27:223–226.
 
25.  Djulepa  J.  Zweijährige  Erfahrung  in  der  Therapie  des  Prosta-Syndroms. Ärztliche Praxis, 1982, 34:2199–2202.
 
26.  Feiber H. Sonographische Verlaufsbeobachtungen zum Einfl uss der medikamentösen  Therapie  der  benignen  Prostatahyperplasie  (BPH).  In:  Bauer HW, ed. Benigne Prostatahyperplasie II, klinische und experimentelle
Urolo
gie 19
. Munich, Zuckschwerdt, 1988
 
27.  Fisher M, Wilbert D. Wirkprüfung eines Phytopharmakons zur Behandlung der  benignen  Prostatahyperplasie  (BPH).  In:  Rutishauser  G,  ed. Benigne Prostatahyperplasie III, klinische und experimentelle Urologie 22. Munich, 
Zuckschwerdt, 1992:79–83.
 
28.  Friesen A. Statistische Analyse einer Multizenter-Langzeitstudie mit ERU. In: Bauer HW, ed. Benigne Prostatahyperplasie II, klinische und experimentelle Urologie 19. Munich, Zuckschwerdt, 1988:121–130.
 
29.   Goetz  P.  Die  Behandlung  der  benignen  Prostatahyperplasie  mit  Brennesselwurzeln. Zeitschrift für Phytotherapie, 1989, 10:175–178.

30. Sonnenschein R. Untersuchung der Wirksamkeit eines prostatotropen Phytotherapeutikums (Urtica plus) bei benigner Prostatahyperplasie und Prostatitis – eine prospektive multizentrische Studie. Urologie [B], 1987, 27:232–237.
 
31.   Stahl  HP.  Die  Therapie  prostatischer  Nykturie. Zeitschrift  für  Allgemeine  Medizin, 1984, 60:128–132.
 
32.  Tosch  U  et  al.  Medikamentöse  Behandlung  der  benignen  Prostatahyperplasie. Euromed, 1983, 6:1–3.
 
33.  Vahlensieck W. Konservative Behandlung der benignen Prostatahyperplasie. Therapiewoche Schweiz, 1986, 2:619–624.
 
34.  Vandierendounck EJ, Burkhardt P. Extractum radicis urticae bei Fibromyoadenom der Prostata mit nächtlicher Pollakisurie. Therapiewoche Schweiz1986, 2:892–895.
 
35.  Vontobel HP et al. Ergebnisse einer Doppelblindstudie über die Wirksamkeit von ERU-Kapseln in der konservativen Behandlung der benignen Prostatahyperplasie. Urologie [A], 1985, 24:49–51.


Health Issues

UK-based trade group the Health Food Manufacturers Association (HFMA) has written a formal letter of complaint to the BBC about a controversial BBC2 Horizon programme about the food supplements industry.

VIEW MORE

Consumers are demanding BPA-free products, but the alternatives are no safer. Despite this alarming data, nearly 81% of Americans have detectable levels of BPS in their urine.

VIEW MORE

Widely promoted as a ‘safe’ and ‘healthy’ alternative way to quit smoking, the adoption of vaping has grown exponentially in recent years.

VIEW MORE